Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities
Albumedix Ltd. ('Albumedix'), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.  
Albumedix Expands Production Capacity at rHA Manufacturing Plant and Opens New Research Facilities
Play
Capacity expansion at the company’s cGMP manufacturing plant in Nottingham, UK will enable Albumedix to support its next wave of clients from pre-clinical development through to market

Related Keywords

United Kingdom ,Nottingham ,Phil Morton ,Jonas Skj ,Stuart Woodward ,Better Health ,Research Facilities ,Albumedix Ltd ,Technology Centre ,Centre Albumedix ,Albumedix Ltd Apr ,From Albumedix Ltd Apr ,United Kingdom Based ,Expands Production Capacity ,Opens New Research ,Albumedix Chief Executive Officer Jonas Skj ,Albumedix Chief Manufacturing Officer Stuart ,Albumedix Chief Technology Officer ,Albumin ,Manufacturing ,Research ,Iopharmaceutical ,Gene ,ஒன்றுபட்டது கிஂக்டம் ,நாட்டிங்ஹாம் ,பில் மோர்டன் ,ஜோனாஸ் ஸ்க்ஜு ,ஸ்டூவர்ட் வூட்வார்ட் ,சிறந்தது ஆரோக்கியம் ,ஆராய்ச்சி வசதிகள் ,தொழில்நுட்பம் மையம் ,ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது ,எனே ,